| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.01 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |